Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis

Figure 3

The expression of hsa-mir-124 was associated with pathologic characteristics in breast invasive carcinoma. The Kruskal–Wallis test was used to detect the association of hsa-mir-124 and pathologic stages in TCGA-BRCA. (a) hsa-mir-124-1, (b) hsa-mir-124-2, and (c) hsa-mir-124-3 in stage I/II/III/IV; (d) hsa-mir-124-1, (e) hsa-mir-124-2, and (f) hsa-mir-124-3 in lymph node metastasis.

(a)

(b)

(c)

(d)

(e)

(f)